LANIGAN BERNARD JR

Director Bernard Lanigan Jr sold 46,119 shares of CNX at $40.60 (-6.7% from 52-week high); holdings reduced 20.7% to 177,180 shares.

Lanigan sold 46,119 shares at $40.60 on 2026-02-19, reducing his stake by 20.7% to 177,180 shares—a material reduction in his direct ownership position at a price near the top of the 52-week range ($28.11–$40.97). His prior five trades at CNX were all buys, with 2 of 5 showing well-timed entry (positive 90-day returns), suggesting selective prior conviction at lower prices. CNX shows strong fundamentals: $583.8M quarterly revenue, +76.8% annual revenue growth, and a 5.35 P/E. The shift from accumulation to a large single sale—despite the company's solid growth backdrop—warrants examination of whether this reflects portfolio rebalancing or a change in the insider's assessment at current valuations.

Director Lanigan buys 75,000 CNX shares at $26.81; holdings jump 22.9% to 401,820 shares post-transaction.

Bernard Lanigan Jr., a director, purchased 75,000 shares of CNX Resources on 2024-09-09 for $2.0M, increasing his holdings by 22.9% to 401,820 shares. The transaction occurred near the company's 52-week range and reflects a substantial personal investment commitment. At CNX specifically, Lanigan's prior 5 trades generated mixed results—one prior buy on 2024-08-20 is still awaiting outcome measurement, while his 2023 purchases showed near-term gains (30d returns +5.3% to +6.6%) but 90-day declines (-8.1% to -8.4%); only 1 of 4 prior measurable CNX trades achieved positive 90-day returns. The company faces headwinds: latest quarterly net income was -$18.3M despite revenue of $321.4M, though year-over-year revenue growth stands at +172.4%.

Director LANIGAN BERNARD JR purchases 75,000 shares of CNX at $26.74, raising stake 29.8% to 326,820 shares

LANIGAN BERNARD JR, a director, purchased 75,000 shares at $26.74 on 2024-08-20, expanding his holdings by 29.8% from 251,820 to 326,820 shares in a $2,005,500 transaction. The purchase occurred near the 52-week high of $27.42, with the stock currently at $27.00 and up +6.0% over 30 days and +8.7% over 90 days. At the same ticker, the insider's prior four trades show mixed timing outcomes: one purchase was well-timed with a 90-day return of +28.8%, while three others produced 90-day losses ranging from -8.1% to -8.4%. CNX itself shows financial stress with net income of $-18.3M in the latest quarter despite strong annual revenue growth of +172.4%, and a notably low P/E of 7.80 on a $4.1B market cap. The coincidence of a substantial position increase at near-52-week-high prices, paired with recent same-ticker underperformance in the 90-day window, and the company's ongoing profitability challenges, presents a data pattern worth monitoring as it unfolds.